Item:Q20484: Difference between revisions

Revision as of 22:29, 4 February 2024 Fire (talk \| contribs) Bureaucrats, Interface administrators, Administrators 132,579 edits ‎Added [en] aliases: (+)-cis-Hexahydro-2-oxo-1H-thieno[3,4]imidazole-4-valeric acid, cis-Tetrahydro-2-oxothieno(3,4-d)imidazoline-4-valeric acid, cis-(+)-Tetrahydro-2-oxothieno[3,4]imidazoline-4-valeric acid, 5-[(1R,5S,6S)-3-oxo-7-thia-2,4-diazabicyclo[3.3.0]oct-6-yl]pentanoic acid, D(+)-Biotin, Hexahydro-2-oxo-1H-thieno(3,4-D)imidazole-4-pentanoate, Hexahydro-2-oxo-[3aS-(3aa,4b,6aa)]-1H-Thieno[3,4-D]imidazole-4-pentanoate, delta-Biotin factor S, 5-(2-Oxohexahydro-1H-thieno[3,4-D]imid... ← Older edit	Revision as of 22:30, 4 February 2024 Fire (talk \| contribs) Bureaucrats, Interface administrators, Administrators 132,579 edits ‎Created claim: instance of (P2): type of chemical entity (Q2546) Newer edit →
	Property / instance of
		type of chemical entity
	Property / instance of: type of chemical entity / rank
		Normal rank